A: Dr. Mahajan specializes in the surgical management of ovarian, cervical, endometrial, and other gynecologic cancers. She performs advanced procedures including cytoreductive surgery, fertility-sparing interventions, minimally invasive laparoscopic and robotic surgeries, and HIPEC for complex cases. Her personalized treatment plans ensure the best possible outcomes for each patient.

Yes, Dr. Mahajan offers fertility-sparing procedures for women diagnosed with gynecologic cancers, enabling them to preserve reproductive potential while receiving effective cancer treatment. She carefully assesses each patient’s condition and provides minimally invasive techniques and individualized plans to maintain both health and fertility whenever feasible.

Surgical management involves the removal of cancerous tissue from organs such as the uterus, ovaries, cervix, or fallopian tubes. Procedures can range from minimally invasive laparoscopic surgery to complex cytoreductive surgeries, depending on the stage and location of the cancer. The goal is to remove the tumor completely while preserving organ function where possible and ensuring optimal long-term outcomes

Surgery is a primary treatment for many gynecologic cancers, but it is often combined with chemotherapy, radiation, or targeted therapies. The treatment plan is personalized based on the cancer type, stage, and patient’s overall health. Surgery aims to remove tumors while other therapies help prevent recurrence and manage advanced disease for a comprehensive, effective treatment approach.

Surgery is a primary treatment for many gynecologic cancers, but it is often combined with chemotherapy, radiation, or targeted therapies. The treatment plan is personalized based on the cancer type, stage, and patient’s overall health. Surgery aims to remove tumors while other therapies help prevent recurrence and manage advanced disease for a comprehensive, effective treatment approach.

Fertility-sparing procedures are surgical interventions designed to treat gynecologic cancers while preserving a woman’s ability to conceive. These procedures carefully remove only the affected tissue and retain healthy reproductive organs. They are suitable for select patients with early-stage cancers and require careful pre-surgical evaluation, planning, and follow-up to ensure both oncological safety and reproductive potential.

Women with early-stage ovarian, cervical, or endometrial cancers who wish to preserve fertility may be considered for these procedures. Eligibility is determined based on tumor type, stage, size, and overall health. Surgeons ensure that cancer removal is complete while minimizing risks to reproductive organs. Patients also receive detailed counseling regarding future pregnancy and long-term monitoring.

Minimally-invasive oncology procedures use small incisions, laparoscopic instruments, or robotic systems to remove tumors with precision. These techniques reduce blood loss, minimize scarring, and shorten recovery time compared to traditional open surgery. They are commonly used in gynecologic oncology for ovarian, cervical, and endometrial cancers, offering safe and effective treatment while enhancing patient comfort and post-operative recovery.

Benefits include smaller incisions, reduced pain, faster recovery, lower risk of infection, and shorter hospital stays. Minimally-invasive procedures also allow for precise tumor removal while preserving healthy tissue and organs. Patients experience quicker return to normal activities and improved overall quality of life, making these procedures a preferred choice for suitable candidates in gynecologic oncology.

Preventive oncological procedures aim to detect cancer early or reduce risk in high-risk individuals. This includes screenings, prophylactic surgeries, and risk-reduction strategies for women with a family history of gynecologic cancers. These procedures help in early detection, timely intervention, and potentially avoiding the development of invasive cancer. Regular monitoring and lifestyle guidance are also part of preventive care.

Women with a family history of ovarian, cervical, or endometrial cancers, genetic predispositions, or other risk factors should consider preventive procedures. Screening tests, imaging, and sometimes prophylactic surgeries can be advised to reduce cancer risk. Early detection and preventive strategies significantly improve outcomes and ensure timely, effective treatment if needed.

Cancer surveillance includes regular follow-ups, imaging, blood tests, and physical examinations to monitor patients after treatment. The goal is to detect recurrence or new cancers early, assess recovery, and manage any long-term treatment effects. Surveillance is essential for maintaining patient health and ensuring timely intervention if any issues arise post-treatment.

The frequency of surveillance depends on the type and stage of cancer, treatment received, and patient-specific risk factors. Typically, follow-ups are more frequent in the first 2–3 years after treatment, gradually spacing out over time. Each patient receives a personalized surveillance schedule to optimize early detection and ongoing health management.

Genetic counselling evaluates a patient’s inherited risk of developing gynecologic cancers, often through family history and genetic testing. It helps patients understand their risk, make informed decisions about preventive measures, and plan early detection strategies. Counselors also guide patients regarding fertility, lifestyle modifications, and personalized treatment options based on genetic predisposition.

Women with a strong family history of ovarian, breast, or endometrial cancers, early-onset cancers, or known genetic mutations (like BRCA1/2) should consider genetic counselling. It helps in identifying high-risk individuals, planning preventive strategies, and making informed decisions regarding surveillance, surgery, or lifestyle adjustments to reduce cancer risk.